Cellebrite DI Ltd. (CLBT) Gross Margin
- Gross margin · 12 months: Value 84.20%; Formula and calculation Gross profit / revenue. Period ending 2025-12-31..
Gross margin
Overview →Financial period ending 2025-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 84.20% | Gross profit / revenue. Period ending 2025-12-31. $400.50M ÷ $475.68M × 100 ≈ 84.20% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 400.50M USD | Gross Profit |
| Revenue | 475.68M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2025-12-31 | $400.50M | $475.68M | (m) | 84.20% |
| 2025-06-30 | $368.50M | $436.73M | (m) | 84.38% |
| 2024-12-31 | $338.61M | $401.20M | (m) | 84.40% |
| 2024-06-30 | $305.17M | $412.53M | (m) | 73.98% |
| 2023-12-31 | $271.88M | $325.11M | (m) | 83.63% |
| 2023-06-30 | $241.51M | $298.14M | (m) | 81.00% |
| 2022-12-31 | $219.91M | $270.65M | (m) | 81.25% |
| 2022-06-30 | $210.38M | $257.79M | (m) | 81.61% |
| 2021-12-31 | $203.69M | $246.25M | (m) | 82.72% |
| 2021-06-30 | (m) | (m) | (m) | (m) |
| 2020-12-31 | $157.03M | $194.91M | (m) | 80.57% |
| 2019-12-31 | $136.03M | $171.85M | (m) | 79.15% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.